Oh, D. Y., Kilari, D., Darr, C., Zarrabi, K. K., Hawley, J. E., Pachynski, R. K., Tagawa, S. T., Yang, Y., Buetikofer, S., Xia, Q., Amsberg, G. V. (2025). A phase 1b, open-label, multicenter study of xaluritamig in patients with newly diagnosed localized intermediate- or high-risk prostate cancer in the neoadjuvant setting.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps434